IPP Bureau
Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal
By IPP Bureau - June 25, 2026
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
Experts call for uniform quality standards for blood and blood components
By IPP Bureau - June 25, 2026
National conference brings together 160+ experts from six states to advance blood quality and safety standards
Mardamed unveils 15,000 sq. ft. HeX Centre integrating healthcare with everyday retail
By IPP Bureau - June 25, 2026
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
By IPP Bureau - June 25, 2026
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
Shilpa Medicare subsidiary settles Rs. 20.13 crore dispute with Sartorius for Rs. 9 crore
By IPP Bureau - June 25, 2026
The resolution significantly reduces a long-standing contingent liability from the company's books
Mankind Pharma launches nationwide preventive oncology initiative to reach one million women
By IPP Bureau - June 25, 2026
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
Eli Lilly India launches Tanstrive for RET-altered cancers
By IPP Bureau - June 25, 2026
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform
By IPP Bureau - June 25, 2026
The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
Girish Bhunje appointed Senior Vice President – API Operations at Intas Pharmaceuticals
By IPP Bureau - June 25, 2026
Intas Pharmaceuticals has appointed Girish Bhunje as Senior Vice President – API Operations
Vishal Rathi appointed Group Head, Product Development at Sandoz India
By IPP Bureau - June 25, 2026
Rathi brings more than 15 years of experience in formulation research and development, with deep expertise across a wide range of dosage forms and drug delivery technologies.
Shilpa Biologicals commissions Integrated ADC drug substance GMP manufacturing facility in Dharwad
By IPP Bureau - June 25, 2026
This makes the company among few in India to offer fully integrated, end-to-end ADC drug substance development and manufacturing, encompassing payload synthesis, linker development and manufacturing
Marco Valencia Sanchez appointed as General Manager of Roche Diagnostics
By IPP Bureau - June 25, 2026
In his 17-year career within Roche, Marco has held key global, regional, and affiliate leadership roles
Celon Laboratories appoints Himal P. Desai as Chief Supply Chain Officer
By IPP Bureau - June 25, 2026
His expertise spans supply chain management, strategic planning, operational transformation, and cross-functional leadership
Microbot Medical wins surgical robotics industry award for LIBERTY Endovascular Robotic System
By IPP Bureau - June 25, 2026
Innovative start-up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit
NPPA integrates Pharma Jan Samadhan Portal with Pharma Sahi Daam Portal
By IPP Bureau - June 25, 2026
Unified digital platform enables medicine price verification and grievance redressal in one place
